Sun Pharma Increases Takeover Bid for Organon to $13 Billion, Driving Share Price Up 30.9%
Sun Pharmaceuticals has increased its takeover bid for Organon (OGN) to $13 billion, leading to a 30.9% surge in Organon's share price. The offer now includes backing from three global lenders, including JPMorgan, MUFG, and Citi. Organon, a reproductive health and women's health company, was spun off from Merck in 2021.
Topics: investment opportunity merger pharmaceutical industry stock price movement takeover